My main aim here is to identify to anyone interested that metformin appears to have an impact of T3 levels.
Whether the hypotheses of the paper make any sense of that observation is, I fear, rather more questionable. (Though I accept is was very much acknowledged to be a pilot study.)
A breakthrough-like effect of metformin reduces peripheral resistance to triiodothyronine in euthyroid, non-insulin-resistant, type 2 diabetic patients
in Endocrine Connections
Authors:Melinda Kertész 1 , Szilárd Kun 1 , Eszter Sélley 1 , Zsuzsanna Nagy 1 , Tamás Kőszegi 2 , and István Wittmann 1
DOI: doi.org/10.1530/EC-21-0218
Volume/Issue: Volume 10: Issue 7
Page Range: 782–788
Article Type: Research Article
Online Publication Date: 21 Jul 2021
Copyright: © The authors 2021
Abstract
Background
Type 2 diabetes is characterized, beyond the insulin resistance, by polyhormonal resistance. Thyroid hormonal resistance has not yet been described in this population of patients. Metformin is used to decrease insulin resistance, and at present, it is assumed to influence the effect of triiodothyronine, as well.
Methods
In this open-label, pilot, hypothesis-generating, follow-up study, 21 patients were included; all of them were euthyroid with drug naïve, newly diagnosed type 2 diabetes. Before and after 4 weeks of metformin therapy, fructosamine, homeostasis model assessment for insulin resistance (HOMA-IR), thyroid hormones, T3/T4 ratio, and TSH, as well as blood pressure and heart rate using ambulatory blood pressure monitor were measured. We also conducted an in vitro study to investigate the possible mechanisms of T3 resistance, assessing T3-induced Akt phosphorylation among normal (5 mM) and high (25 mM) glucose levels with or without metformin treatment in a human embryonal kidney cell line.
Results
Metformin decreased the level of T3 (P < 0.001), the ratio of T3/T4 (P= 0.038), fructosamine (P= 0.008) and HOMA-IR (P= 0.022). All these changes were accompanied by an unchanged TSH, T4, triglyceride, plasma glucose, bodyweight, blood pressure, and heart rate. In our in vitro study, T3-induced Akt phosphorylation decreased in cells grown in 25 mM glucose medium compared to those in 5 mM. Metformin could not reverse this effect.
Conclusion
Metformin seems to improve T3 sensitivity in the cardiovascular system in euthyroid, type 2 diabetic patients, the mechanism of which may be supracellular.
Keywords: insulin resistance; metformin; ratio of T3/T4; triiodothyronine resistance; type 2 diabetes mellitus
Full text freely available here: